Clinicopathologic characteristics of breast cancer in BRCA-carriers and non-carriers in women 35 years of age or less

Breast

Volumn 23, Issue 6, 2014, Pages 770-774

  Bayraktar, Soley ^a   Amendola, Laura ^b   Gutierrez Barrera, Angelica M ^a   Hashmi, Syed S ^c   Amos, Chris ^a   Gambello, Michael ^d   Ready, Kaylene J ^a   Arun, Banu ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b UNIVERSITY OF WASHINGTON MEDICAL CENTER   (United States)

^c UNIVERSITY OF TEXAS SCHOOL OF PUBLIC HEALTH   (United States)

^d UNIVERSITY OF HOUSTON   (United States)

Author keywords

BMI; BRCA; Breast cancer; Family history; Male breast cancer; Parity

Indexed keywords

ESTROGEN RECEPTOR; EPIDERMAL GROWTH FACTOR RECEPTOR 2; ERBB2 PROTEIN, HUMAN; PROGESTERONE RECEPTOR;

ADULT; ARTICLE; BREAST CANCER; CANCER STAGING; FAMILY HISTORY; FEMALE; GENE MUTATION; HETEROZYGOTE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE BREAST CANCER; MENARCHE; OVARY CANCER; PREGNANCY; TUMOR SUPPRESSOR GENE; AGE; BODY MASS; BREAST TUMOR; CASE CONTROL STUDY; FACTUAL DATABASE; GENETICS; LYMPH NODE; MEDULLARY CARCINOMA; METABOLISM; MUTATION; PAGET NIPPLE DISEASE; PATHOLOGY; REPRODUCTIVE HISTORY;

ADULT; AGE FACTORS; BODY MASS INDEX; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CARCINOMA, MEDULLARY; CASE-CONTROL STUDIES; DATABASES, FACTUAL; FEMALE; GENES, BRCA1; GENES, BRCA2; HETEROZYGOTE; HUMANS; LYMPH NODES; MUTATION; RECEPTOR, ERBB-2; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; REPRODUCTIVE HISTORY;

EID: 84922024955     PISSN: 09609776     EISSN: 15323080     Source Type: Journal    
DOI: 10.1016/j.breast.2014.08.010     Document Type: Article

References (33)

1. Mintzer D., Glassburn J., Mason B.A., Sataloff D. Breast cancer in the very young patient: a multidisciplinary case presentation. Oncologist 2002, 7:547-554.
2. Noyes R.D., Spanos W.J., Montague E.D. Breast cancer in women aged 30 and under. Cancer 1982, 49:1302-1307.
3. Shannon C., Smith I.E. Breast cancer in adolescents and young women. Eur J Cancer 2003, 39:2632-2642.
4. Kwon J.S., Gutierrez-Barrera A.M., Young D., Sun C.C., Daniels M.S., Lu K.H., et al. Expanding the criteria for BRCA mutation testing in breast cancer survivors. JClin Oncol 2010, 28:4214-4220.
5. Begg C.B., Haile R.W., Borg A., Malone K.E., Concannon P., Thomas D.C., et al. Variation of breast cancer risk among BRCA1/2 carriers. JAMA 2008, 299:194-201.
6. Szabo C.I., King M.C. Population genetics of BRCA1 and BRCA2. Am J Hum Genet 1997, 60:1013-1020.
7. Ford D., Easton D.F., Stratton M., Narod S., Goldgar D., Devilee P., et al. Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium. Am J Hum Genet 1998, 62:676-689.
8. King M.C., Marks J.H., Mandell J.B. Breast and ovarian cancer risks due to inherited mutations in BRCA1 and BRCA2. Science 2003, 302:643-646.
9. Chen S., Iversen E.S., Friebel T., Finkelstein D., Weber B.L., Eisen A., et al. Characterization of BRCA1 and BRCA2 mutations in a large United States sample. JClin Oncol 2006, 24:863-871.
10. Schwartz G.F., Hughes K.S., Lynch H.T., Fabian C.J., Fentiman I.S., Robson M.E., et al. Proceedings of the international consensus conference on breast cancer risk, genetics, & risk management. Cancer 2007, 113:2627-2637.
11. Nkondjock A., Ghadirian P. Epidemiology of breast cancer among BRCA mutation carriers: an overview. Cancer Lett 2004, 205:1-8.
12. Nussbaum S.R. Prevention: the cornerstone of quality health care. Am J Prev Med 2006, 31:107-108.
13. Foulkes W.D., Metcalfe K., Sun P., et al. Estrogen receptor status in BRCA1- and BRCA2-related breast cancer: the influence of age, grade, and histological type. Clin Cancer Res 2004, 10:2029-2034.
14. Peto J., Collins N., Barfoot R., Seal S., Warren W., Rahman N., et al. Prevalence of BRCA1 and BRCA2 gene mutations in patients with early-onset breast cancer. JNatl Cancer Inst 1999, 91:943-949.
15. Lord S.J., Bernstein L., Johnson K.A., Malone K.E., McDonald J.A., Marchbanks P.A., et al. Breast cancer risk and hormone receptor status in older women by parity, age of first birth, and breastfeeding: a case-control study. Cancer Epidemiol Biomark Prev 2008, 17:1723-1730.
16. Seventh edition of the AJCC cancer staging manual and handbook 2010.
17. The World Health Organization histological typing of breast tumors-second edition (1982) the World Organization. Am J Clin Pathol 78: 806-816.
18. Black M.M., Speer F.D. Nuclear structure in cancer tissues. Surg Gynecol Obstet 1957, 105:97-102.
19. Zabicki K., Colbert J.A., Dominguez F.J., et al. Breast cancer diagnosis in women < or= 40 versus 50 to 60 years: increasing size and stage disparity compared with older women over time. Ann Surg Oncol 2006, 13:1072-1077.
20. Tryggvadóttir L., Tulinius H., Eyfjord J.E., Sigurvinsson T. Breast cancer risk factors and age at diagnosis: an Icelandic cohort study. Int J Cancer 2002, 98:604-608.
21. Kotsopoulos J., Lubinski J., Lynch H.T., Kim-Sing C., Neuhausen S., Demsky R., et al. Oophorectomy after menopause and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers. Cancer Epidemiol Biomark Prev 2012, 21:1089-1096.
22. Trapido E.J. Age at first birth, parity, and breast cancer risk. Cancer Causes Control 1983, 51:946-948.
23. Clavel-Chapelon F., Gerber M. Reproductive factors and breast cancer risk. Do they differ according to age at diagnosis?. Breast Cancer Res Treat 2002, 72:107-115.
24. Velentgas P., Daling J.R. Risk factors for breast cancer in younger women. JNatl Cancer Inst Monogr 1994, 16:15-24.
25. Kotsopoulos J.L.C., Lubinski J., Gronwald J., Kim-Sing C., Ghadirian P., Lynch H.T., et al. Hereditary Breast Cancer Clinical Study Group. Infertility, treatment of infertility, and the risk of breast cancer among women with BRCA1 and BRCA2 mutations: a case-control study. Cancer Causes Control 2008, 19(10):1111-1119.
26. McCredie M.R., Dite G.S., Giles G.G., Hopper J.L. Breast cancer in Australian women under the age of 40. Cancer Causes Control 1998, 9:189-198.
27. Gonzalez-Angulo A.M., Broglio K., Kau S.W., et al. Women age < or= 35 years with primary breast carcinoma: disease features at presentation. Cancer 2005, 103:2466-2472.
28. Kenen R., Ardern-Jones A., Eeles R. Family stories and the use of heuristics: women from suspected hereditary breast and ovarian cancer (HBOC) families. Sociol Health Illn 2003, 25:838-865.
29. Narod S.A. Modifiers of risk of hereditary breast cancer. Oncogene 2006, 25:5832-5836.
30. Frank T.S., Deffenbaugh A.M., Hulick M., Gumpper K. Hereditary susceptibility to breast cancer: significance of age of onset in family history and contribution of BRCA1 and BRCA2. Dis Markers 1999, 15:89-92.
31. Lakhani S.R., Jacquemier J., Sloane J.P., et al. Multifactorial analysis of differences between sporadic breast cancers and cancers involving BRCA1 and BRCA2 mutations. JNatl Cancer Inst 1998, 90:1138-1145.
32. Atchley D.P., Albarracin C.T., Lopez A., Valero V., Amos C.I., Gonzalez-Angulo A.M., et al. Clinical and pathologic characteristics of patients with BRCA-positive and BRCA-negative breast cancer. JClin Oncol 2008, 26:4282-4288.
33. Lakhani S.R., Van De Vijver M.J., Jacquemier J., Anderson T.J., Osin P.P., McGuffog L., et al. The pathology of familial breast cancer: predictive value of immunohistochemical markers estrogen receptor, progesterone receptor, HER-2, and p53 in patients with mutations in BRCA1 and BRCA2. JClin Oncol 2002, 20:2310-2318.